ICU MEDICAL INC/DE - Common Stock (ICUI) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ICUI on Nasdaq
Underlying class
Common Stock
Shares outstanding
24,701,460
Price per share
$142.68
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
25,798,861
Total reported value
$3,091,750,564
% of total 13F portfolios
0%
Share change
+719,121
Value change
+$75,847,655
Number of holders
267
Price from insider filings
$142.68
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ICU MEDICAL INC/DE - Common Stock (ICUI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 10% 0% $303,729,152 +$253,298 2,470,146 +0.08% JANUS HENDERSON GROUP PLC 30 Jun 2025

As of 30 Sep 2025, 267 institutional investors reported holding 25,798,861 shares of ICU MEDICAL INC/DE - Common Stock (ICUI). This represents 104% of the company’s total 24,701,460 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ICU MEDICAL INC/DE - Common Stock (ICUI) together control 86% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 14% 3,521,591 -1.2% 0.01% $422,450,057
VANGUARD GROUP INC 11% 2,624,991 -1.3% 0% $314,893,920
JANUS HENDERSON GROUP PLC 10% 2,473,536 +0.14% 0.14% $296,724,701
FULLER & THALER ASSET MANAGEMENT, INC. 5.6% 1,385,155 -0.35% 0.56% $166,163,180
MILLENNIUM MANAGEMENT LLC 4.4% 1,089,017 +173% 0.1% $130,638,479
STATE STREET CORP 3.7% 917,125 -1.2% 0% $110,018,315
DIMENSIONAL FUND ADVISORS LP 3.5% 872,993 +17% 0.02% $104,718,042
AMERIPRISE FINANCIAL INC 3.3% 803,542 +34% 0.02% $96,393,067
SCHRODER INVESTMENT MANAGEMENT GROUP 3.2% 796,704 +25% 0.07% $93,246,236
JPMORGAN CHASE & CO 2.7% 676,370 -11% 0.01% $81,137,344
River Road Asset Management, LLC 2.6% 651,156 -0.05% 0.88% $78,112,674
NEUBERGER BERMAN GROUP LLC 2.6% 641,946 +24% 0.06% $77,007,842
GEODE CAPITAL MANAGEMENT, LLC 2.4% 593,328 -1.8% 0% $71,185,268
MORGAN STANLEY 2.3% 565,186 +5% 0% $67,799,797
SILVERCREST ASSET MANAGEMENT GROUP LLC 1.8% 432,766 +31% 0.34% $51,915,023
UBS Group AG 1.6% 386,555 +240% 0.01% $46,371,138
NORTHERN TRUST CORP 1.6% 385,895 -0.7% 0.01% $46,291,963
FMR LLC 1.5% 365,279 -19% 0% $43,818,838
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.2% 307,232 +0.24% 0.01% $36,855,551
FEDERATED HERMES, INC. 1.2% 290,292 +56% 0.06% $34,823,429
MACQUARIE GROUP LTD 1.2% 285,791 +2.2% 0.04% $34,283,000
SEGALL BRYANT & HAMILL, LLC 1.1% 280,521 -5.1% 0.45% $33,651,299
GOLDMAN SACHS GROUP INC 1.1% 278,714 +39% 0% $33,434,471
Quantinno Capital Management LP 1% 252,449 +87% 0.08% $30,283,782
BANK OF AMERICA CORP /DE/ 1% 249,663 -20% 0% $29,949,573

Institutional Holders of ICU MEDICAL INC/DE - Common Stock (ICUI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 57,118 $8,201,943 +$826,751 $142.68 12
2025 Q3 25,798,861 $3,091,750,564 +$75,847,655 $119.96 267
2025 Q2 25,082,538 $3,314,262,195 +$97,749,020 $132.15 273
2025 Q1 24,312,384 $3,381,986,336 +$22,039,376 $138.86 281
2024 Q4 24,213,328 $3,756,901,128 -$19,911,411 $155.17 285
2024 Q3 24,218,800 $4,406,301,481 +$45,477,085 $182.22 285
2024 Q2 23,699,208 $2,814,260,627 +$177,324,886 $118.75 258
2024 Q1 22,289,638 $2,391,831,274 +$85,264,774 $107.32 249
2023 Q4 515,476 $51,413,577 -$4,127,340 $99.74 5
2023 Q3 21,843,759 $2,599,636,515 -$32,819,360 $119.01 210
2023 Q2 22,058,736 $3,930,358,938 -$106,555,213 $178.19 225
2023 Q1 22,493,609 $3,710,352,101 +$70,644,802 $164.96 229
2022 Q4 22,292,055 $3,511,343,615 +$39,625,610 $157.48 239
2022 Q3 22,192,926 $3,342,432,469 -$249,566,366 $150.60 224
2022 Q2 21,402,140 $3,514,120,324 +$83,693,773 $164.39 240
2022 Q1 20,101,696 $4,477,806,794 +$166,511,770 $222.64 276
2021 Q4 20,184,298 $4,789,733,796 +$34,948,200 $237.34 285
2021 Q3 19,963,244 $4,659,807,119 -$53,959,847 $233.38 270
2021 Q2 20,301,468 $4,177,506,142 +$45,866,323 $205.80 265
2021 Q1 19,992,988 $4,107,045,855 +$107,860,764 $205.44 276
2020 Q4 19,413,703 $4,163,765,760 +$42,048,343 $214.49 268
2020 Q3 19,213,817 $3,511,519,488 -$32,199,973 $182.76 264
2020 Q2 19,354,744 $3,566,471,688 +$14,762,295 $184.31 275
2020 Q1 18,706,246 $3,772,994,076 -$38,982,645 $201.77 252
2019 Q4 19,581,056 $3,663,742,363 +$109,087,974 $187.12 256
2019 Q3 19,160,569 $3,057,689,839 -$158,720,704 $159.60 242
2019 Q2 19,472,910 $4,902,774,191 +$281,555,365 $251.91 262
2019 Q1 18,700,178 $4,475,111,288 -$78,104,607 $239.33 282
2018 Q4 19,041,285 $4,372,398,825 +$711,407,534 $229.63 283
2018 Q3 15,694,365 $4,437,384,496 +$195,157,141 $282.75 343
2018 Q2 15,060,738 $4,422,740,852 +$112,578,706 $293.65 338
2018 Q1 14,871,461 $3,747,465,037 -$171,381,845 $252.40 284
2017 Q4 15,560,557 $3,361,346,374 -$74,420,189 $216.00 252
2017 Q3 15,894,228 $2,954,192,388 +$33,761,333 $185.85 223
2017 Q2 15,721,033 $2,704,907,238 +$283,155,390 $172.50 223
2017 Q1 15,518,724 $2,369,669,740 +$296,452,853 $152.70 226
2016 Q4 15,005,968 $2,210,869,263 +$104,941,586 $147.35 241
2016 Q3 14,293,007 $1,805,896,453 +$26,102,227 $126.38 224
2016 Q2 14,301,488 $1,612,490,710 -$1,702,322 $112.75 212
2016 Q1 14,224,957 $1,480,813,514 +$24,437,050 $104.10 208
2015 Q4 13,963,167 $1,574,576,427 -$22,418,905 $112.78 221
2015 Q3 14,287,444 $1,564,470,155 -$35,515,204 $109.50 203
2015 Q2 14,532,645 $1,390,174,180 +$22,897,062 $95.66 192
2015 Q1 14,255,826 $1,327,597,061 +$32,269,570 $93.14 182
2014 Q4 14,150,736 $1,159,233,343 +$12,686,238 $81.90 192
2014 Q3 14,294,440 $917,422,365 -$3,369,802 $64.18 170
2014 Q2 14,342,852 $872,175,036 +$2,572,254 $60.81 159
2014 Q1 13,957,343 $835,726,039 +$39,037,277 $59.88 165